Hans Keirstead
Company: Immunis Inc
Job title: Chairman
Seminars:
Immune Secretomes Targeting Age-Acquired Immune Decline 12:00 pm
Discussing the association of aging and a decline in secretory factors that benefit immune system development, modulation and health Describing the novel method of growing human stem cells for clinical use and directing them to produce a secretome (STEM) Revealing an FDA-approved Phase 1/2a human clinical trial to test the safety and efficacy of STEM…Read more
day: Day Two
Chair’s Closing Remarks 5:00 pm
day: Day Two